Clinical Disclaimer: For clinician education only; not patient-specific medical advice.
Welcome to the March 20, 2026, edition of Fertility Insights. This week marked a definitive shift in the reproductive landscape as we moved from “suggestive” AI models to predictive automation. Today’s briefing highlights the newly published multicenter validation of Digital Twin Ovarian Stimulation, the arrival of niPGT-A 2.0 protocols, and the clinical implementation of robotic sperm recovery for severe male-factor cases.
🔬 Clinical Deep Dive: The ‘Digital Twin’ in Ovarian Stimulation
The trial-and-error nature of gonadotropin dosing is being replaced by “Digital Twin” modelling. The InOvaSGuide framework, recently updated in late Q1 2026, uses a patient’s multi-omic and follicular data to simulate cycle outcomes before the first injection.
• The Mechanism: Using Gradient Boosting Regressors, the AI creates a virtual model of the patient’s ovarian response. It plots an Individualised Dose-Response Curve, allowing clinicians to visualise the trade-off between the Number of Oocytes Retrieved (NOR) and the statistical risk of OHSS.
• Performance: The model achieved an R² of 0.79 for NOR prediction, significantly outperforming traditional protocols based on AMH/BMI alone.
• Clinical Impact: This allows for “precision-triggering,” where the medication is adjusted in real-time based on the synchronisation of the entire follicular cohort, not just the lead follicles.
• Citation: “Integrated Prediction System for Individualised Ovarian Stimulation and OHSS Prevention,” JMIR (2026) / PMID: [41229699].
🤖 Automated Follicle Intelligence: The FOLLISCAN Success
Manual ultrasound variability has long been a source of “cycle noise.” The FOLLISCAN multicenter trial (published Jan/March 2026) has demonstrated that AI-driven volumetrics are now a clinical necessity for standardised care.
• Data Points: Across 5,508 scans globally, the AI achieved 98.2% precision for follicles ≥ 10 mm.
• Efficiency: Automated annotation reduced probe-contact time by 66% and total annotation time by 2.5x. This allows senior clinicians to focus on strategy rather than manual measurement.
• Internal Resource: Explore our Precision Ovarian Stimulation Protocols at Santaan.
• Citation: “An artificial intelligence platform for automated measurement of ovarian follicles: a multicenter study.” JARG (2026) / PMID: [41485151].
🧬 Genetic Screening: niPGT-A 2.0 and Day 6 Optimisation
Non-invasive PGT-A is shedding its “investigational” tag. Research published this month (March 2026) reveals that laboratory protocol shifts, specifically extending culture to Day 6, have solved previous cfDNA informative rate issues.
• Key Finding: Extending the culture time increased the informative rate of cell-free DNA (cfDNA) analysis from 69.4% to 97.9%.
• Ploidy Concordance: Concordance with traditional trophectoderm biopsy is now approaching 76–80% when using optimised washing protocols to eliminate maternal DNA contamination.
• Internal Resource: Discover Santaan’s Advanced AI-Driven Lab Technology.
• Citation: “Clinical application progress and prospects of niPGT: A review.” Clin Chim Acta (2026) / DOI: 10.1016/j.cca.2026.120945.
🧪 Andrology: Robotic STAR Recovery for Azoospermia
For patients with non-obstructive azoospermia (NOA), the search for a single sperm is no longer a manual “needle-in-a-haystack” task. The STAR (Sperm Tracking and Recovery) system, developed at Columbia University, is now clinically operational.
• Technology: Using astrophysics-inspired imaging, STAR scans 8 million images per hour, identifying rare viable sperm cells invisible to human embryologists.
• Automation: A robotic arm retrieves the identified sperm via microfluidics, preventing the mechanical stress and oxidative damage caused by high-speed centrifugation.
• Citation: “Columbia University STAR method: The Best Inventions of 2025/2026,” TIME (2025/2026).
📈 Santaan’s Scientific Leadership
At Santaan, we believe in Human-in-the-Loop AI. Technology should provide the precision, but the clinician provides the wisdom. For a deeper technical analysis of how our Vision Transformer (ViT) architecture integrates with these workflows, visit our specialist briefings: Santaan IVF on Medium.
Connect With Us
For Clinicians: Stay ahead of the technology curve. Join our digital health network to access real-time AI benchmarks and advanced diagnostic support for your complex cases.
👉 Contact our Clinical Relations Team
https://www.google.com/search?q=https://santaan.in/contact-us
Technical Metadata